Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.75 |
| ▸ | RAB9A | P51151 | 2/20 | 0.75 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 6/20 | 0.53 |
| ▸ | CA12 | O43570 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23718278 | 0.90 | ALDH1A1 (0.75) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL6312050 | 0.89 | ALDH1A1 (0.58) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL26978013 | 0.86 | ALDH1A1 (1.00) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL16787630 | 0.85 | ALDH1A1 (0.82) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL4948312 | 0.84 | ALDH1A1 (0.81) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL6527991 | 0.84 | ALDH1A1 (0.81) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL1195022 | 0.84 | ALDH1A1 (0.81) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL1143334 | 0.83 | ALDH1A1 (1.00) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL1356015 | 0.82 | ALDH1A1 (0.79) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD | |
| SCHEMBL3599042 | 0.82 | ALDH1A1 (0.78) | ALDH1A1RAB9ATSHRSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3801455-B1 | MILD COMPOSITION FOR USE IN TOPICAL TREATMENT OF SKIN AND NAIL DISORDERS CAUSED BY VIRUS AND FUNGUS | EVIDERM INST AB (SE) | 2025-05-21 | — | — | EP | claimed |
| EP-3810067-B1 | METHODS OF INHIBITING MICROBIAL INFECTIONS USING ZINC-CONTAINING COMPOSITIONS | TRIUMPH PHARMACEUTICALS INC (US) | 2025-04-16 | — | — | EP | claimed |
| EP-4301323-B1 | ORAL CARE COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-01-29 | — | — | EP | claimed |
| EP-3721862-B1 | ORAL CARE PREPARATIONS COMPRISING CHLORHEXIDINE AND ARGININE OR THEIR SALTS | MEDA AB (SE) | 2024-07-24 | — | — | EP | claimed |
| EP-3212293-B1 | COMPOSITION COMPRISING STYLING POWDER AND/OR SEBUM-ABSORBING POWDER AND A ZINC SALT | OREAL (FR) | 2022-10-05 | — | — | EP | claimed |
| US-12359080-B2 | Aqueous dispersion of capsules | AGFA-GEVAERT NV (BE) | 2025-07-15 | — | — | US | disclosed |
| EP-2459163-B2 | SKIN CARE COMPOSITIONS, IN PARTICULAR AGAINST HYDROPHOBIC (LIPOPHILIC) AND HYDROPHILIC (LYPOPHOBIC) CONTAMINANTS | DEB IP LTD (GB) | 2025-04-16 | — | — | EP | disclosed |
| EP-4403371-A1 | POLYMER LAYER COMPOSITE FOR SECURITY AND VALUABLE DOCUMENTS, PRODUCTION METHOD, PREPARATION AND USE | Bundesdruckerei GmbH (DE) | 2024-07-24 | — | — | EP | disclosed |
| EP-3890875-B1 | AQUEOUS DISPERSION OF CAPSULES | AGFA GEVAERT NV (BE) | 2024-01-10 | — | — | EP | disclosed |
| US-20220041878-A1 | AQUEOUS DISPERSION OF CAPSULES | AGFA-GEVAERT NV (BE) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041878-A1 | AQUEOUS DISPERSION OF CAPSULES | RER1, CHRM1, CRHR1 | ALDH1A1 2372/4885RAB9A 4143/4885TSHR 760/4885 |
| US-12359080-B2 | Aqueous dispersion of capsules | RER1, CHRM1, CRHR1 | ALDH1A1 2372/4885RAB9A 4143/4885TSHR 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.